Management of Osteoporotic Vertebral Fracture: Review Update 2022
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 장해동 | - |
dc.contributor.author | Kim Eung-Ha | - |
dc.contributor.author | Lee Jae Chul | - |
dc.contributor.author | 최성우 | - |
dc.contributor.author | Kim Hak Soo | - |
dc.contributor.author | Cha Joong-Suk | - |
dc.contributor.author | Shin Byung-Joon | - |
dc.date.accessioned | 2023-03-09T07:41:15Z | - |
dc.date.available | 2023-03-09T07:41:15Z | - |
dc.date.created | 2023-02-17 | - |
dc.date.issued | 2022-12 | - |
dc.identifier.issn | 1976-1902 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/22177 | - |
dc.description.abstract | A vertebral fracture is the most common type of osteoporotic fracture. Osteoporotic vertebral fractures (OVFs) cause a variety of morbidities and deaths. There are currently few “gold standard treatments” outlined for the management of OVFs in terms of quantity and quality. Conservative treatment is the primary treatment option for OVFs. The treatment of pain includes short-term bed rest, analgesic medication, anti-osteoporotic medications, exercise, and a brace. Numerous reports have been made on studies for vertebral augmentation (VA), including vertebroplasty and kyphoplasty. There is still debate and controversy about the effectiveness of VA in comparison with conservative treatment. Until more robust data are available, current evidence does not support the routine use of VA for OVF. Despite the fact that the majority of OVFs heal without surgery, 15%–35% of patients with an unstable fracture, persistent intractable back pain, or severely collapsed vertebra that causes a neurologic deficit, kyphosis, or chronic pseudarthrosis frequently require surgery. Because no single approach can guarantee the best surgical outcomes, customized surgical techniques are required. Surgeons must stay current on developments in the osteoporotic spine field and be open to new treatment options. Osteoporosis management and prevention are critical to lowering the risk of future OVFs. Clinical studies on bisphosphonate’s effects on fracture healing are lacking. Teriparatide was intermittently administered, which dramatically improved spinal fusion and fracture healing while lowering mortality risk. According to the available literature, there are no standard management methods for OVFs. More multimodal approaches, including conservative and surgical treatment, VA, and medications that treat osteoporosis and promote fracture healing, are required to improve the quality of the majority of guidelines. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한척추외과학회 | - |
dc.title | Management of Osteoporotic Vertebral Fracture: Review Update 2022 | - |
dc.title.alternative | Management of Osteoporotic Vertebral Fracture: Review Update 2022 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 장해동 | - |
dc.contributor.affiliatedAuthor | Lee Jae Chul | - |
dc.contributor.affiliatedAuthor | 최성우 | - |
dc.contributor.affiliatedAuthor | Shin Byung-Joon | - |
dc.identifier.doi | 10.31616/asj.2022.0441 | - |
dc.identifier.bibliographicCitation | Asian Spine Journal, v.16, no.6, pp.934 - 946 | - |
dc.relation.isPartOf | Asian Spine Journal | - |
dc.citation.title | Asian Spine Journal | - |
dc.citation.volume | 16 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 934 | - |
dc.citation.endPage | 946 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART002912174 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Spine | - |
dc.subject.keywordAuthor | Osteoporosis | - |
dc.subject.keywordAuthor | Spinal fractures | - |
dc.subject.keywordAuthor | Vertebroplasty | - |
dc.subject.keywordAuthor | Kyphoplasty | - |
dc.subject.keywordAuthor | Neurology | - |
dc.subject.keywordAuthor | Teriparatide | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.